Baldness Cure University Of Pennsylvania

What the future holds for hair restoration?

Restore lost hair due to hereditary factors, the dream of many men and women who suffer from hair loss. Until not long ago, the only true and effective options that seek to reverse the loss of hair were nonsurgical camouflage. Only with the advent of follicular unit transplantation and discover the true cause of baldness – the harmful effects of dihydrotestosterone (DHT) in hair follicles – the possibilities the victim's hair loss is to reverse their natural state have greatly improved.

The three best weapons in the fight against hair loss are available today the two drugs approved by the FDA – Finasteride (Propecia) and minoxidil (Rogaine / Regaine) and surgery, hair transplantation and follicular unit, above all, the technique follicular unit extraction. However, there is still no definitive cure each of the three methods of hair restoration has its limitations. Minoxidil and Finasteride work and at the vertex of the scalp and finasteride can not be used by women. Hair transplantation is only suitable for people who have sufficient density Hair in the donor area, and many women, who generally suffer from diffuse thinning, are not good candidates for hair transplant surgery.

Therefore, Science the world are constantly seeking new approaches to the treatment of baldness. There are several promising new drugs and new development techniques listed below, but progress seems to have slowed down lately because of the global financial crisis, some of R & D increasingly difficult to obtain funding for future research.

The most progress has been made (for more information, please visit: http://www.greyhairloss.com/blog/dutasteride-for-hair-loss.html .) Dutasteride is an anti-androgen, in their chemical structure and mode of action is similar to finasteride. Used to treat benign prostatic hyperplasia (BPH) and since it is an inhibitor of 5-alpha reductase marriage, should be more powerful DHT blocker finasteride. Therefore, it is supposed to be more effective in the treatment of hair loss, especially in the frontal scalp area. Dutasteride has completed Phase III clinical trials this year and the results of the study will be published shortly.

NEOSH101 was originally developed by the U.S. Medical research firm and NEOSIL until recently was the subject Phase IIb clinical trial. End 2008, was acquired by NEOSIL Peplin, Inc., a specialty pharmaceutical development stage company and since then no other information about clinical trials is published. In previous clinical trials, has revealed NEOSH101 most potent hair growth and act more quickly, challenging as minoxidil and requires the application once a day. Despite significant improvements in current options for hair loss, NEOSH101 not become the ultimate solution for baldness. Clinical trials seem to move more slowly than the majority of victims falling hair and wishes, therefore, do not hold your breath until they hit the market soon.

Another promising area of development is the pursuit of telomerase. Telomerase is an enzyme that is able to curb the natural telomere shortening and thereby protect. Telomerase maintains and genome integrity. reduced telomeres are not associated with the process of premature aging. However, uncontrolled activation telomerase can trigger cancer. Cancer Research is the main priority of the studies of telomerase but scientists are also looking for other applications such as anti-aging drugs and drugs against baldness and gray hair. Search telomerase could really change the world of medicine, but its application trade could be a good 15 years away.

Hair multiplication, often called hair cloning or hair restoration, is the hope next treatment option under study. This technique involves removing hair follicles from the back of the patient's scalp, culture and multiply, and inject the newly grown outer hair cells bald. Health care in the UK company Intercytex seems to be the leader of the multiplication Hair research. Intercytex has already completed Phase II trial of ICX-TRC (a suspension of its own dermal papilla cells from a patient). The main advantage of the proliferation of hair is the solution to the shortage of donor hair, which is the most limiting factor in hair transplantation. However, now faces Intercytex financial difficulties after failing to find an investor, it will work on their own. Aderans, Intercytex's main competitor, has also recently launched a phase II clinical trial on the basis of the regeneration of hair cells in men and women.

Generate new follicles in the skin wounds without hair is a completely new approach to hair loss regrowth. It was discovered accidentally when an injured skin in mice began to produce new hair. This technology is being developed by the American Society of medical devices, entreaties, this technology has enabled the University of Pennsylvania. Although this method may seem strange, it is said that the use of common tools and drugs that have already been approved by doctors and so it might not have much time to be available the public.

This list of ongoing projects in the field of research includes the hair loss the most promising lines of development, but not exhaustive. However, no new therapies, with the exception of the application Dutasteride for treating hair loss in men is expected to reach the market before 2013 and the immediate future of hair restoration is to improve surgical techniques, increasing the performance of the method of extraction units follicular and make it more affordable for a large proportion of the population.

About the Author

For more information on novel as well as existing treatments for hair loss and gray hair and for hair loss product reviews written by real consumers, please visit the author’s website and do not be ashamed to contribute your own review on the hair treatments and therapies you have used, in order to help others assess the potency of existing hair loss treatment options.

New Cure For Baldness (Using Mice) – INVENT [BroadbandTV]


Incoming search terms for the article: